Human CD20 (Research Grade Rituximab Biosimilar) Alexa Fluor® 488-conjugated Antibody
Human CD20 (Research Grade Rituximab Biosimilar) Alexa Fluor® 488-conjugated Antibody Summary
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Detection of MS4A1/CD20 in Human PBMCs by Flow Cytometry. Human PBMC were stained with (A) Human Anti-Human CD20 (Research Grade Rituximab Biosimilar) Alexa Fluor® 488-conjugated Monoclonal Antibody (Catalog # FAB9575G) or (B) Human Anti-Human IGF-I R/IGF1R (Research Grade Teprotumumab Biosimilar) Alexa Fluor® 488-conjugated Monoclonal Antibody (Catalog # FAB9718G, irrelevant antibody) and Mouse anti-Human CD19 PE-conjugated Monoclonal Antibody (Catalog # FAB4867P). View our protocol for Staining Membrane-associated Proteins.
Preparation and Storage
- 12 months from date of receipt, 2 to 8 °C as supplied.
Rituximab is a biosimilar directed against the extracellular domain of CD20. This antibody can be used in flow cytometry or various assay formats to measure CD20 expression.
Product Specific Notices
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
No product specific FAQs exist for this product, however you mayView all Antibody FAQs
Reviews for Human CD20 (Research Grade Rituximab Biosimilar) Alexa Fluor® 488-conjugated Antibody
There are currently no reviews for this product. Be the first to review Human CD20 (Research Grade Rituximab Biosimilar) Alexa Fluor® 488-conjugated Antibody and earn rewards!
Have you used Human CD20 (Research Grade Rituximab Biosimilar) Alexa Fluor® 488-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image